HER3 as biomarker and therapeutic target in pancreatic cancer: new insights in pertuzumab therapy in preclinical models. Oncotarget, 5(16), 7138–7148.
Our publications
Since its creation, Institut Roche has translated its expertise into numerous successful scientific publications
A cancer model for the angiogenic switch. Journal of theoretical biology, 360, 21–33.
Viger, L., Denis, F., Rosalie, M., & Letellier, C. (2014).
https://doi.org/10.1016/j.jtbi.2014.06.020Phosphoantigens and butyrophilin 3A1 induce similar intracellular activation signaling in human TCRVγ9+ γδ T lymphocytes. Immunology letters, 161(1), 133–137.
Decaup, E., Duault, C., Bezombes, C., Poupot, M., Savina, A., Olive, D., & Fournié, J. J. (2014).
https://doi.org/10.1016/j.imlet.2014.05.011High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial. Leukemia, 28(12), 2367–2375.
Rossille, D., Gressier, M., Damotte, D., Maucort-Boulch, D., Pangault, C., Semana, G., Le Gouill, S., Haioun, C., Tarte, K., Lamy, T., Milpied, N., Fest, T., Groupe Ouest-Est des Leucémies et Autres Maladies du Sang, & Groupe Ouest-Est des Leucémies et Autres Maladies du Sang (2014).
https://doi.org/10.1038/leu.2014.137Vasculature analysis of patient derived tumor xenografts using species-specific PCR assays: evidence of tumor endothelial cells and atypical VEGFA-VEGFR1/2 signalings. BMC cancer, 14, 178.
Bieche, I., Vacher, S., Vallerand, D., Richon, S., Hatem, R., De Plater, L., Dahmani, A., Némati, F., Angevin, E., Marangoni, E., Roman-Roman, S., Decaudin, D., & Dangles-Marie, V. (2014).
https://doi.org/10.1186/1471-2407-14-178Impact of a second opinion using expression and molecular analysis of FOXL2 for sex cord-stromal tumors. A study of the GINECO group & the TMRO network. Gynecologic oncology, 132(1), 181–187.
Maillet, D., Goulvent, T., Rimokh, R., Vacher-Lavenu, M. C., Pautier, P., Alexandre, J., Pujade-Laurraine, E., Devouassoux-Shisheboran, M., Treilleux, I., Ray-Coquard, I., & Savina, A. (2014).
https://doi.org/10.1016/j.ygyno.2013.10.013Cell growth in aggregates determines gene expression, proliferation, survival, chemoresistance, and sensitivity to immune effectors in follicular lymphoma. The American journal of pathology, 184(1), 282–295.
Gravelle, P., Jean, C., Familiades, J., Decaup, E., Blanc, A., Bezombes-Cagnac, C., Laurent, C., Savina, A., Fournié, J. J., & Laurent, G. (2014).
https://doi.org/10.1016/j.ajpath.2013.09.018Mitochondrial oxidative stress is the Achille’s heel of melanoma cells resistant to Braf-mutant inhibitor. Oncotarget, 4(11), 1986–1998.
Corazao-Rozas, P., Guerreschi, P., Jendoubi, M., André, F., Jonneaux, A., Scalbert, C., Garçon, G., Malet-Martino, M., Balayssac, S., Rocchi, S., Savina, A., Formstecher, P., Mortier, L., Kluza, J., & Marchetti, P. (2013).
https://doi.org/10.18632/oncotarget.1420Prediction of Shrinkage of Individual Parameters Using the Bayesian Information Matrix in Non-Linear Mixed Effect Models with Evaluation in Pharmacokinetics. Pharm Res 30, 2355–2367 (2013).